The findings of this study reveal significant racial disparities in MF/SS clinical trial enrollment. Identifying these disparities and investigating barriers to enrollment ensures that MF/SS patients of all racial backgrounds are appropriately represented at each phase of the experimental process. .
Rookwood et al. (Thu,) studied this question.